CAR T cell therapy

‘Immunotherapy effectively has given a fourth pillar of cancer therapy besides surgery, radiation therapy and chemical therapy,’ said UCLA Health’s Dr. Antoni Ribas

By uclahealth • January 6, 2022

Dr. John Timmerman and Dr. Sarah Larson answer questions about CAR T cell therapy

By Denise Heady • September 23, 2020

https://youtu.be/aqwBBnBspwk In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson Comprehensive Cancer Center has established an international reputation for providing the best in leading-edge [...]

By uclahealth • November 13, 2019

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma. What is CAR T-cell therapy? Immunotherapy [...]

By uclahealth • October 7, 2019

Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery. To date, the U.S. Food and Drug Administration (FDA) has approved [...]

By uclahealth • February 11, 2019